A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. (Q42992074)
Jump to navigation
Jump to search
scientific article published in May 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. |
scientific article published in May 2005 |
Statements
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C (English)
A Mangia
G L Ricci
N Minerva
V Carretta
D Bacca
M Cela
M Piattelli
M Annese
G Maio
D Conte
V Guadagnino
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference